LOGIN
AAOS 2016: TXA reduces total blood loss in extra-capsular hip fractures
March 2016
AAOS 2016: TXA reduces total blood loss in extra-capsular hip fractures
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Tranexamic Acid (TXA) Reduces Blood Loss in Patients with Hip Fractures; Results of a Randomized Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
72 patients undergoing extra-capsular hip fracture surgery were randomized to administered either tranexamic acid (TXA) or placebo. The purpose of this study was to determine the efficacy of TXA for reducing total blood loss compared to a saline control group. Secondary outcomes included transfusion rate and 90-day mortality rate. Findings indicated significantly lower blood loss in the TXA group ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.